213 related articles for article (PubMed ID: 23052941)
1. Bisphosphonate treatment and risk of esophageal cancer: a meta-analysis of observational studies.
Sun K; Liu JM; Sun HX; Lu N; Ning G
Osteoporos Int; 2013 Jan; 24(1):279-86. PubMed ID: 23052941
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.
Wright E; Schofield PT; Molokhia M
BMJ Open; 2015 Dec; 5(12):e007133. PubMed ID: 26644118
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates and atrial fibrillation: systematic review and meta-analysis.
Loke YK; Jeevanantham V; Singh S
Drug Saf; 2009; 32(3):219-28. PubMed ID: 19338379
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate use and the risk of breast cancer: a meta-analysis of published literature.
Liu Y; Zhao S; Chen W; Hu F; Zhu L; Zhang Q; Zhao Y
Clin Breast Cancer; 2012 Aug; 12(4):276-81. PubMed ID: 22622199
[TBL] [Abstract][Full Text] [Related]
7. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
[TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates for breast cancer.
Pavlakis N; Schmidt R; Stockler M
Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies.
Ou YJ; Chiu HF; Wong YH; Yang CC; Yang YH
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1286-1295. PubMed ID: 28857419
[TBL] [Abstract][Full Text] [Related]
11. Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis.
Lee SH; Chang SS; Lee M; Chan RC; Lee CC
Osteoporos Int; 2014 Mar; 25(3):1131-9. PubMed ID: 24343364
[TBL] [Abstract][Full Text] [Related]
12. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M;
Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594
[TBL] [Abstract][Full Text] [Related]
13. Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.
Morden NE; Munson JC; Smith J; Mackenzie TA; Liu SK; Tosteson AN
Osteoporos Int; 2015 Feb; 26(2):663-72. PubMed ID: 25349053
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer.
Andrici J; Tio M; Eslick GD
Aliment Pharmacol Ther; 2012 Oct; 36(8):708-16. PubMed ID: 22966908
[TBL] [Abstract][Full Text] [Related]
15. More on reports of esophageal cancer with oral bisphosphonate use.
Solomon DH; Patrick A; Brookhart MA
N Engl J Med; 2009 Apr; 360(17):1789-90; author reply 1791-2. PubMed ID: 19391255
[No Abstract] [Full Text] [Related]
16. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
Wright E; Schofield PT; Seed P; Molokhia M
PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate adverse effects, lessons from large databases.
Abrahamsen B
Curr Opin Rheumatol; 2010 Jul; 22(4):404-9. PubMed ID: 20473174
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of bisphosphonates in osteoporosis.
Watts NB; Diab DL
J Clin Endocrinol Metab; 2010 Apr; 95(4):1555-65. PubMed ID: 20173017
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate Use and Risk of Implant Revision after Total Hip/Knee Arthroplasty: A Meta-Analysis of Observational Studies.
Teng S; Yi C; Krettek C; Jagodzinski M
PLoS One; 2015; 10(10):e0139927. PubMed ID: 26444555
[TBL] [Abstract][Full Text] [Related]
20. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
